Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

450.903
-2.583-0.57%
Number of Gainers:8
Number of Losers:37
Number of Flat:6
PE:- -
High:455.223
Open:453.447
Low:445.681
Close:453.486
Volume:529.76M
Turnover:10.46B
Market Cap:2.85T
Float Cap:1.98T

Loading ...

Cloud Providers Take the AI Torch as Hong Kong Internet Giants Surge, Tracking Index Jumps 4%

Deep News
·
Sep 04

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

Stock News
·
Sep 04

Wuxi Apptec's Target Price Raised to HK$262 by CLSA on Outperform Rating

Deep News
·
Sep 04

Genscript Biotech - on 14 August, Listing Committee Confirmed Company May Proceed with Proposed Spin-Off.

THOMSON REUTERS
·
Sep 04

Genscript Biotech Drops Most in 17 Months on Unit Spinoff Proposal

Reuters
·
Sep 04

Citi Says Meituan-W Can Withstand Ongoing Macro and Competitive Pressures, Reaffirms Buy Rating

Stock News
·
Sep 04

Chinese Pharma Companies Plan Hong Kong Listings

Dow Jones
·
Sep 04

Genscript Biotech Proposes Spin-Off and Separate Listing of Probio Technology

Reuters
·
Sep 04

Genscript Biotech Proposes Separate Listing of Subsidiary on Hong Kong Main Board

Stock News
·
Sep 04

Genscript Biotech - Proposed Spin-Off and Separate Listing of Probio Technology Limited

THOMSON REUTERS
·
Sep 04

Simcere Pharmaceutical Announces Approval for Marketing of Yingmule in China by NMPA

Reuters
·
Sep 03

Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment to the Co

Reuters
·
Sep 03

Robot Maker's Market Value Drops Over 220 Billion Amid Slowing Growth and Management Scrutiny

Deep News
·
Sep 03

Simcere Says China Approves RSV Prevention Antibody Yingmule for Infants

Reuters
·
Sep 03

Simcere Pharmaceutical - Approval for Marketing of Yingmule in China by National Medical Products Administration

THOMSON REUTERS
·
Sep 03

Everest Medicines Gets China Nod for CARDAMYST Application

MT Newswires Live
·
Sep 03

ZYLOXTB (02190) Allocates HK$1.12 Million for Share Buyback on September 3

Stock News
·
Sep 03

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback

Reuters
·
Sep 03

Everest Medicines Says China NMPA Approves Cardamyst Nasal Spray for PSVT Conversion in Adults

Reuters
·
Sep 03

Everest Medicines - Nmpa Approves Cardamyst (Etripamil) Nda for Psvt in Adults in China

THOMSON REUTERS
·
Sep 03